CARDENE I.V. dosage forms and strengths: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Nicardipine}} {{CMG}}; {{AE}}:{{AK}} '''''For patient information about Nicardipine, click here.''''' Cardene I.V. Premixed..." |
No edit summary |
||
Line 5: | Line 5: | ||
'''''For patient information about Nicardipine, click [[Nicardipine (patient information)|here]].''''' | '''''For patient information about Nicardipine, click [[Nicardipine (patient information)|here]].''''' | ||
Cardene I.V. Premixed Injection is supplied as a single-use, ready-to-use, iso-osmotic solution for intravenous administration in a 200 mL GALAXY container with 40 mg (0.2 mg/mL) nicardipine hydrochloride in either dextrose or sodium chloride.{{ | Cardene I.V. Premixed Injection is supplied as a single-use, ready-to-use, iso-osmotic solution for intravenous administration in a 200 mL GALAXY container with 40 mg (0.2 mg/mL) nicardipine hydrochloride in either dextrose or sodium chloride.<ref> {{cite web | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8ef8420-01d2-11de-a455-0002a5d5c51b | title = CARDENE I.V. (nicardipine hydrochloride) injection, solution [EKR Therapeutics, Inc.] |accessdate = }}</ref> | ||
==References== | |||
{{Reflist|2}} | |||
{{FDA}} | |||
[[Category:Cardiovascular Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 16:28, 20 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]
For patient information about Nicardipine, click here.
Cardene I.V. Premixed Injection is supplied as a single-use, ready-to-use, iso-osmotic solution for intravenous administration in a 200 mL GALAXY container with 40 mg (0.2 mg/mL) nicardipine hydrochloride in either dextrose or sodium chloride.[1]
References
Adapted from the FDA Package Insert.